• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CSL:AU

79.0100 AUD 0.6200 0.78%

As of 19:24:54 ET on 11/24/2014.

Snapshot for CSL Ltd (CSL)

Open: 78.6600 Day's Range: 78.6200 - 79.3300 Volume: 261,024
Previous Close: 79.6300 52wk Range: 63.7700 - 80.4400 1-Yr Rtn: +17.54%

Stock Chart for CSL

No chart data available.
  • CSL:AU 78.9800
  • 1D
  • 1M
  • 1Y
79.6300
Interactive CSL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CSL

Current P/E Ratio (ttm) 25.4049
Estimated P/E(06/2015) 22.0603
Relative P/E vs. AS51 1.3828
Earnings Per Share (USD) (ttm) 2.7014
Est. EPS (USD) (06/2015) 3.1090
Est. PEG Ratio 1.6729
Market Cap (M AUD) 37,826.68
Shares Outstanding (M) 475.03
30 Day Average Volume 1,357,264
Price/Book (mrq) 10.2192
Price/Sale (ttm) 6.1716
Dividend Indicated Gross Yield 1.55%
Cash Dividend (AUD) 0.6485
Dividend Ex-Date 09/08/2014
5 Year Dividend Growth 12.07%
Next Earnings Announcement 02/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CSL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CSL

CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection and pain medicine, skin disorder remedies, antivenoms, anticoagulants and immunoglobulins.

John ShineChairmanPaul PerreaultCEO/Managing Director
Gordon NaylorChief Financial OfficerMary SontropExec VP:Manufacturing
More Company Profile & Key Executives for CSL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil